| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.38 | 0.02 |